Literature DB >> 27435003

Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2.

A-K Eisfeld1, J Kohlschmidt1,2, K Mrózek1, J S Blachly3, D Nicolet1,2, K Kroll3, S Orwick1, A J Carroll4, R M Stone5, A de la Chapelle1, J C Byrd3, C D Bloomfield1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27435003      PMCID: PMC5244485          DOI: 10.1038/leu.2016.196

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   12.883


× No keyword cloud information.
  14 in total

1.  Trisomy 11: prevalence among 22,403 unique patient cytogenetic studies and clinical correlates.

Authors:  D Caramazza; R P Ketterling; R A Knudson; C A Hanson; S Siragusa; A Pardanani; A Tefferi
Journal:  Leukemia       Date:  2010-04-01       Impact factor: 11.528

2.  Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia.

Authors:  Sarah Abu Kar; Anna Jankowska; Hideki Makishima; Valeria Visconte; Andres Jerez; Yuka Sugimoto; Hideki Muramatsu; Fabiola Traina; Manuel Afable; Kathryn Guinta; Ramon V Tiu; Bartlomiej Przychodzen; Hirotoshi Sakaguchi; Seiji Kojima; Mikkael A Sekeres; Alan F List; Michael A McDevitt; Jaroslaw P Maciejewski
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

3.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

Authors:  David Grimwade; Robert K Hills; Anthony V Moorman; Helen Walker; Stephen Chatters; Anthony H Goldstone; Keith Wheatley; Christine J Harrison; Alan K Burnett
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

4.  The partial tandem duplication of ALL1 in acute myeloid leukemia with normal cytogenetics or trisomy 11 is restricted to one chromosome.

Authors:  M A Caligiuri; M P Strout; A R Oberkircher; F Yu; A de la Chapelle; C D Bloomfield
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.

Authors:  Susan P Whitman; Shujun Liu; Tamara Vukosavljevic; Laura J Rush; Li Yu; Chunhui Liu; Marko I Klisovic; Kati Maharry; Martin Guimond; Matthew P Strout; Brian Becknell; Adrienne Dorrance; Rebecca B Klisovic; Christoph Plass; Clara D Bloomfield; Guido Marcucci; Michael A Caligiuri
Journal:  Blood       Date:  2005-03-17       Impact factor: 22.113

6.  Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis.

Authors:  Tobias Herold; Klaus H Metzeler; Sebastian Vosberg; Luise Hartmann; Christoph Röllig; Friedrich Stölzel; Stephanie Schneider; Max Hubmann; Evelyn Zellmeier; Bianka Ksienzyk; Vindi Jurinovic; Zlatana Pasalic; Purvi M Kakadia; Annika Dufour; Alexander Graf; Stefan Krebs; Helmut Blum; Maria Cristina Sauerland; Thomas Büchner; Wolfgang E Berdel; Bernhard J Woermann; Martin Bornhäuser; Gerhard Ehninger; Ulrich Mansmann; Wolfgang Hiddemann; Stefan K Bohlander; Karsten Spiekermann; Philipp A Greif
Journal:  Blood       Date:  2014-06-12       Impact factor: 22.113

7.  Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.

Authors:  Christine Steudel; Martin Wermke; Markus Schaich; Ulrike Schäkel; Thomas Illmer; Gerhard Ehninger; Christian Thiede
Journal:  Genes Chromosomes Cancer       Date:  2003-07       Impact factor: 5.006

8.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Authors:  Timothy J Ley; Christopher Miller; Li Ding; Benjamin J Raphael; Andrew J Mungall; A Gordon Robertson; Katherine Hoadley; Timothy J Triche; Peter W Laird; Jack D Baty; Lucinda L Fulton; Robert Fulton; Sharon E Heath; Joelle Kalicki-Veizer; Cyriac Kandoth; Jeffery M Klco; Daniel C Koboldt; Krishna-Latha Kanchi; Shashikant Kulkarni; Tamara L Lamprecht; David E Larson; Ling Lin; Charles Lu; Michael D McLellan; Joshua F McMichael; Jacqueline Payton; Heather Schmidt; David H Spencer; Michael H Tomasson; John W Wallis; Lukas D Wartman; Mark A Watson; John Welch; Michael C Wendl; Adrian Ally; Miruna Balasundaram; Inanc Birol; Yaron Butterfield; Readman Chiu; Andy Chu; Eric Chuah; Hye-Jung Chun; Richard Corbett; Noreen Dhalla; Ranabir Guin; An He; Carrie Hirst; Martin Hirst; Robert A Holt; Steven Jones; Aly Karsan; Darlene Lee; Haiyan I Li; Marco A Marra; Michael Mayo; Richard A Moore; Karen Mungall; Jeremy Parker; Erin Pleasance; Patrick Plettner; Jacquie Schein; Dominik Stoll; Lucas Swanson; Angela Tam; Nina Thiessen; Richard Varhol; Natasja Wye; Yongjun Zhao; Stacey Gabriel; Gad Getz; Carrie Sougnez; Lihua Zou; Mark D M Leiserson; Fabio Vandin; Hsin-Ta Wu; Frederick Applebaum; Stephen B Baylin; Rehan Akbani; Bradley M Broom; Ken Chen; Thomas C Motter; Khanh Nguyen; John N Weinstein; Nianziang Zhang; Martin L Ferguson; Christopher Adams; Aaron Black; Jay Bowen; Julie Gastier-Foster; Thomas Grossman; Tara Lichtenberg; Lisa Wise; Tanja Davidsen; John A Demchok; Kenna R Mills Shaw; Margi Sheth; Heidi J Sofia; Liming Yang; James R Downing; Greg Eley
Journal:  N Engl J Med       Date:  2013-05-01       Impact factor: 91.245

9.  Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.

Authors:  Timothy A Graubert; Dong Shen; Li Ding; Theresa Okeyo-Owuor; Cara L Lunn; Jin Shao; Kilannin Krysiak; Christopher C Harris; Daniel C Koboldt; David E Larson; Michael D McLellan; David J Dooling; Rachel M Abbott; Robert S Fulton; Heather Schmidt; Joelle Kalicki-Veizer; Michelle O'Laughlin; Marcus Grillot; Jack Baty; Sharon Heath; John L Frater; Talat Nasim; Daniel C Link; Michael H Tomasson; Peter Westervelt; John F DiPersio; Elaine R Mardis; Timothy J Ley; Richard K Wilson; Matthew J Walter
Journal:  Nat Genet       Date:  2011-12-11       Impact factor: 38.330

10.  High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.

Authors:  Hsiao-Wen Kao; D Cherng Liang; Ming-Chung Kuo; Jin-Hou Wu; Po Dunn; Po-Nan Wang; Tung-Liang Lin; Yu-Shu Shih; Sung-Tzu Liang; Tung-Huei Lin; Chen-Yu Lai; Chun-Hui Lin; Lee-Yung Shih
Journal:  Oncotarget       Date:  2015-10-20
View more
  9 in total

1.  Adult chronic myelomonocytic leukemia with trisomy 11: a case report.

Authors:  S H Yoo; J Lim; J M Byun; J H Park; K H Kim; I S Choi
Journal:  Curr Oncol       Date:  2017-12-20       Impact factor: 3.677

2.  Isolated trisomy 11 in patients with acute myeloid leukemia - is the prognosis not as grim as previously thought?

Authors:  Jan Philipp Bewersdorf; Rory M Shallis; Autumn Diadamo; Lohith Gowda; Nikolai A Podoltsev; Alexa Siddon; Amer M Zeidan
Journal:  Leuk Lymphoma       Date:  2020-04-26

Review 3.  BCOR gene alterations in hematologic diseases.

Authors:  Paolo Sportoletti; Daniele Sorcini; Brunangelo Falini
Journal:  Blood       Date:  2021-12-16       Impact factor: 22.113

4.  Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers.

Authors:  Julie E Feusier; Sasi Arunachalam; Tsewang Tashi; Monika J Baker; Chad VanSant-Webb; Amber Ferdig; Bryan E Welm; Juan L Rodriguez-Flores; Christopher Ours; Lynn B Jorde; Josef T Prchal; Clinton C Mason
Journal:  Blood Cancer Discov       Date:  2021-03-03

5.  The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia.

Authors:  A-K Eisfeld; K Mrózek; J Kohlschmidt; D Nicolet; S Orwick; C J Walker; K W Kroll; J S Blachly; A J Carroll; J E Kolitz; B L Powell; E S Wang; R M Stone; A de la Chapelle; J C Byrd; C D Bloomfield
Journal:  Leukemia       Date:  2017-03-24       Impact factor: 11.528

Review 6.  BCOR involvement in cancer.

Authors:  Annalisa Astolfi; Michele Fiore; Fraia Melchionda; Valentina Indio; Salvatore N Bertuccio; Andrea Pession
Journal:  Epigenomics       Date:  2019-05-31       Impact factor: 4.778

7.  Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3-ITD AML.

Authors:  Daelynn R Buelow; Stanley B Pounds; Yong-Dong Wang; Lei Shi; Yongjin Li; David Finkelstein; Sheila Shurtleff; Geoffrey Neale; Hiroto Inaba; Raul C Ribeiro; Reid Palumbo; Dominique Garrison; Shelley J Orwick; James S Blachly; Karl Kroll; John C Byrd; Tanja A Gruber; Jeffrey E Rubnitz; Sharyn D Baker
Journal:  Clin Transl Sci       Date:  2019-08-20       Impact factor: 4.689

8.  Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group.

Authors:  Yann Ferret; Nicolas Boissel; Nathalie Helevaut; Jordan Madic; Olivier Nibourel; Alice Marceau-Renaut; Maxime Bucci; Sandrine Geffroy; Karine Celli-Lebras; Sylvie Castaigne; Xavier Thomas; Christine Terré; Hervé Dombret; Claude Preudhomme; Aline Renneville
Journal:  Haematologica       Date:  2018-02-22       Impact factor: 11.047

Review 9.  Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Cancers (Basel)       Date:  2020-08-26       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.